XRP News Today: Ripple's Abu Dhabi Approval Fuels Blockchain Healthcare Revolution

Generated by AI AgentCoin WorldReviewed byShunan Liu
Thursday, Nov 27, 2025 6:49 am ET1min read
Speaker 1
Speaker 2
AI Podcast:Your News, Now Playing
Aime RobotAime Summary

- Ripple's RLUSD stablecoin gains ADGM approval as a regulated fiat-referenced token, boosting institutional adoption in the Middle East.

-

launches HIPAA-grade XRPH Wallet in U.S. and East Africa, targeting $595B healthcare markets with real-time XRP/RLUSD payments.

- Wallet enables 3-5 second settlements at <$0.001 fees, aiming to capture 3-5% of a $595B market through blockchain-driven pharmacy networks.

- Low-cost cross-border settlements and open-source design position RLUSD and XRPL as transformative tools for healthcare liquidity and supply chains.

Ripple's RLUSD stablecoin has received regulatory approval in Abu Dhabi, marking a significant step in institutional adoption of digital assets in the Middle East. The Abu Dhabi Global Market (ADGM) Financial Services Regulatory Authority (FSRA)

, enabling licensed entities within the financial center to use the stablecoin for regulated activities. This endorsement underscores ADGM's role as a hub for innovation in financial technology, aligning with its reputation for stringent regulatory standards. Ripple's move complements its recent approvals from other UAE regulators, solidifying RLUSD's position as a compliant settlement asset in the region.

The approval coincides with broader expansion efforts by

Healthcare LLC, a company leveraging the XRP Ledger (XRPL) to develop healthcare payment solutions. The firm has into the U.S. and East African pharmacy markets, targeting a combined $595 billion healthcare sector. The wallet enables real-time payments in XRP, XRPH, and RLUSD, with settlement finality in 3–5 seconds and fees under $0.001. This aligns with Ripple's stablecoin's growing utility in cross-border and institutional transactions, particularly in markets where low-cost, high-speed settlements are critical.

The U.S. and East African healthcare landscapes present vast opportunities for blockchain adoption. In the U.S., 68,000+ pharmacies and 200,000+ outpatient clinics form a $535 billion pharmacy market, while East Africa's 45,000+ pharmacies and 100,000+ clinics represent a sector

. XRP Healthcare projects capturing 3–5% of this combined market within five years, translating to 12,000–20,000 healthcare providers and tens of millions of blockchain-settled transactions annually. Such growth could drive systemic cost reductions through near-zero-fee payments and streamline liquidity cycles for cross-border medical supply chains.

The XRPH Wallet's features-open-source code, HIPAA-grade privacy, and support for multiple currencies-position it as a unique solution in a sector transitioning toward digital-first payments. With global healthcare transactions valued at $3.5 trillion in 2024,

could catalyze adoption. Ripple's RLUSD, now sanctioned by ADGM, further enhances the ecosystem by providing a stable, regulated medium for these transactions.